Vir Biotechnology Inc (VIR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2022 | 12-2021 | 09-2021 | 06-2021 | 03-2021 | |
| Sales | 1,232,459 | 812,755 | 103,616 | 177,068 | 1,976 |
| Cost of Goods | 90,149 | 56,885 | 7,836 | 1,144 | N/A |
| Gross Profit | 1,142,310 | 755,870 | 95,780 | 175,924 | 1,976 |
| Operating Expenses | 128,631 | 185,003 | 150,001 | 115,051 | 160,609 |
| Operating Income | 1,013,828 | 571,752 | -53,385 | 61,017 | -158,633 |
| Other Income | -91,921 | -25,863 | 164,147 | 849 | -10,082 |
| Pre-tax Income | 921,907 | 545,889 | 110,762 | 61,866 | -168,715 |
| Income Tax | 403,286 | 20,635 | 334 | 53 | 196 |
| Net Income Continuous | 518,621 | 525,254 | 110,428 | 61,813 | -168,911 |
| Net Income | $518,621 | $525,254 | $110,428 | $61,813 | $-168,911 |
| EPS Basic Total Ops | 3.93 | 4.06 | 0.85 | 0.48 | -1.32 |
| EPS Basic Continuous Ops | 3.93 | 4.07 | 0.85 | 0.48 | -1.32 |
| EPS Diluted Total Ops | 3.85 | 4.00 | 0.82 | 0.46 | -1.32 |
| EPS Diluted Continuous Ops | 3.85 | 4.00 | 0.83 | 0.46 | -1.32 |
| EBITDA(a) | $1,016,453 | $573,888 | $-52,520 | $61,772 | $-156,822 |